Finds lncRNA Cyrano mediates the degradation of miR-7 in the ischemic brain, suggesting therapeutic targets for stroke recovery.
Transient focal ischemia rapidly disrupts the expression of various noncoding RNAs, including miRNAs, which regulate brain injury and recovery. Among these, miR-7, which is a pro-survival miRNA, is downregulated in the ischemic brain, leading to derepression of its target α-synuclein, which promotes neuronal death. In the brain, miR-7 levels are influenced by the circRNA CDR1as, which stabilizes miR-7, and lncRNA Cyrano, which facilitates its degradation. Following transient focal ischemia, CDR1as levels significantly decreased, while pri-miR-7 levels were unchanged, suggesting that mature miR-7 is reduced due to increased post-transcriptional degradation. Bioinformatics analysis revealed strong sequence complementarity between Cyrano and miR-7. Experimentally, Cyrano was upregulated in the ischemic brain and capable of binding and degrading free miR-7. Cyrano knockout mice showed increased cerebral miR-7 levels after ischemia, whereas miR-7 knockout didn’t affect Cyrano levels. Importantly, mice lacking Cyrano showed improved motor recovery and less brain damage after transient focal ischemia, likely due to reduced α-Synuclein levels. These findings reveal that noncoding RNA crosstalk regulates miRNA stability and function in the brain after stroke.
No takes yet. Share an insight, caveat, or question.
Mehta et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: